Voronoi보로노이
310210 · KOSDAQ · ₩310210 · 보로노이
₩121,100▲ ₩2,300 (1.94%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (VRN110755의 제 1/2상 임상시험)Oct 20, 2026Open on DART
Predicted impact: Low
- Investor relations (IR) event기업설명회(IR)개최Oct 13, 2026Open on DART
Predicted impact: Low· Actual: +5.6% vs sector, volume 0.8× normal (5 trading days)
- Material Matters Report (Decision on Acquisition of Own Convertible Bonds Before Maturity)주요사항보고서(자기전환사채만기전취득결정)Oct 8, 2026Open on DART
- Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Oct 2, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)Sep 18, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Sep 17, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (VRN110755의 제 1/2상 임상시험)Sep 14, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Sep 10, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)Sep 9, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획자진취하등) (VRN110755의 제 1/2상 임상시험)Sep 9, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Sep 9, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (VRN110755의 제 1/2상 임상시험)Sep 7, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 31, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 28, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Aug 21, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (VRN110755의 제 1/2상 임상시험)Aug 18, 2026Open on DART
- Added attachment: Half-year report (Jun 2026)[첨부추가]반기보고서 (2026.06)Aug 14, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)Aug 7, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (VRN110755의 제 1/2상 임상시험)Jul 31, 2026Open on DART
- [Attached Correction] Major Matters Report (Designation of Party Exercising Convertible Bond Purchase Option)[첨부정정]주요사항보고서(전환사채매수선택권행사자지정)Jul 30, 2026Open on DART
- [Amended Filing] Major Matters Report (Exercise of Convertible Bond Call Option Designation)[기재정정]주요사항보고서(전환사채매수선택권행사자지정)Jul 30, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)Jul 8, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 3, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 3, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)Jun 25, 2026Open on DART
- [Corrected] Material Matters Report (Early Redemption of Own Convertible Bonds Decision)[기재정정]주요사항보고서(자기전환사채만기전취득결정)Jun 24, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)Jun 23, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jun 23, 2026Open on DART
- Material Matters Report (Decision on Acquisition of Own Convertible Bonds Before Maturity)주요사항보고서(자기전환사채만기전취득결정)Jun 23, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)Jun 22, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)Jun 22, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 22, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)Jun 10, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 8, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jun 2, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (VRN110755의 제 1/2상 임상시험)May 27, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)May 27, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (VRN110755의 제 1/2상 임상시험)May 26, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최May 13, 2026Open on DART
- Major Matters Report (Exercise of Convertible Bond Call Option Designation)주요사항보고서(전환사채매수선택권행사자지정)May 8, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 15, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 15, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 15, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: Voronoi / 보로노이 / 310210 / KRX:310210
Source: KRX statistical information